The Man Who Wrote the DSM Warned Us About Overdiagnosis — So Why Not Gender? - Allen Frances (#8)
Dr Allen Frances chaired the DSM-IV Task Force and spent decades warning that psychiatry was over-diagnosing and over-medicating ordinary human distress. His philosophy — diagnose cautiously, wait and see, resist pharmaceutical expansion — aligns closely with the conclusions of the Cass Review. But when the Beyond Gender hosts probe him on gender dysphoria, the conversation shifts unexpectedly. Frances declines to apply his own framework consistently, describing himself as confused. This episode captures a real intellectual tension: the man who wrote the rulebook on diagnostic caution stopping short of his own logic when it comes to gender medicine.
When Dr Allen Frances agreed to join the Beyond Gender podcast, it seemed a natural fit. The psychiatrist who chaired the DSM-IV Task Force spent years sounding the alarm about psychiatry's expanding definitions of illness, the pharmaceutical industry's appetite for new patient markets, and the human cost of labelling ordinary suffering as disorder. He became one of the most prominent voices for diagnostic caution in modern psychiatry, and few guests could have arrived with more relevant credentials. The early discussion covers familiar Frances territory. He argues that diagnoses should be temporary tools rather than lifelong identities, that mild distress is being reclassified as disorder to suit commercial interests, and that watchful waiting is a seriously undervalued option in psychiatry. For British listeners who followed the Cass Review closely, these arguments will ring with particular force. Dame Hilary Cass reached strikingly similar conclusions about gender-distressed young people at the Tavistock: that insufficient weight had been given to the possibility that distress might resolve naturally, and that medical pathways were adopted with a confidence the evidence did not support. The conversation takes a sharper turn when gender dysphoria enters the discussion. Here the episode becomes genuinely illuminating — not because Frances joins the hosts in their critique, but because he does not. He acknowledges confusion, describes the picture as complicated, and resists the framing that the surge in referrals is straightforwardly explained by social contagion. It is a notable moment: a man who built his career on scepticism about diagnostic expansion declining to apply that same scepticism consistently. The hosts push back, respectfully but firmly, and the resulting exchange is one of the more intellectually honest conversations the podcast has produced. What Frances's position inadvertently demonstrates is the inconsistency that critics of affirmative-care orthodoxy have long identified. The principles he applies everywhere else — be slow to diagnose, distrust pharmaceutical incentives, recognise that social pressures can drive clinical presentations — do not, in his view, apply with equal force to gender dysphoria. He describes himself as confused, which is at least candid. But for families navigating NHS waiting lists and clinicians working under NHS England's guidance on puberty blockers, confusion is a luxury they cannot afford. The episode also touches on detransition and the emerging wave of legal action, a trend gathering pace in Britain where a growing number of detransitioners have launched or signalled claims against NHS trusts. Frances's comments on this are cautious, but the legal dimension is one British audiences will recognise as increasingly significant following the Cass Report and the subsequent withdrawal of puberty blockers from routine NHS clinical care. Taken as a whole, this episode offers something unusual: a high-profile psychiatric figure whose own intellectual framework seems to demand one conclusion about medicalised gender distress, yet who arrives at a different one. That gap is worth sitting with. The Cass Review asked the NHS to close exactly that kind of gap between principle and practice. The conversation with Allen Frances shows how difficult that closure can be, even for the experts.
